Shares of Panacea Biotec advanced for the fourth straight day and were locked in 20 per cent upper circuit at Rs 211 on the BSE on Tuesday on the back of heavy volumes.
The biotechnology company's stock hit a 52-week high and surpassed its previous high of Rs 210, touched on April 24, 2019. It has rallied 64 per cent in the past four trading days, against 1.3 per cent rise in the S&P BSE Sensex. In the past one month, Panacea Biotec's stock price has more-than-doubled from the level of Rs 101, as compared to 6.6 per cent
The biotechnology company's stock hit a 52-week high and surpassed its previous high of Rs 210, touched on April 24, 2019. It has rallied 64 per cent in the past four trading days, against 1.3 per cent rise in the S&P BSE Sensex. In the past one month, Panacea Biotec's stock price has more-than-doubled from the level of Rs 101, as compared to 6.6 per cent